Amgen

Welcome to the 'Amgen' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Amgen'.

Latest blogosphere posts tagged “Amgen”

• Enbrel web banner

  
  AdPharm Blog — Authority: 146
  Click here to see it on AdPharm AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here .
  1 day ago

• Enbrel web banner

  
  AdPharm Blog — Authority: 146
  Click here to see it on AdPharm AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here .
  2 days ago

• Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News

  
  Xconomy — Authority: 710
  Roundup , Biotech , deals Luke Timmerman wrote: This was the week that a little biotech company in Bothell that few of the locals have ever heard of, burst onto the national stage. —Bothell, WA-based Alder Biopharmaceuticals had its breakout moment this week when it pulled in $85 million in upfront ...
  2 days ago

• Amgens troubles keep compounding; Aranesp studies reveal greater risks

  
  DailyFinance — Authority: 794
  Filed under: Company News , Healthcare It seems that when it comes to Aranesp, its blockbuster anemia drug, Amgen ( AMGN ) just cant catch a break, nor for that matter, create one. Recently, Amgen was hit with a double whammy -- a lawsuit and an unfavorable study of the drug. On Tuesday, yet another study ...
  3 days ago

• Alder Rides Momentum of $1B Deal, Aims to Give Amgen and Abbott a Run for Their Money

  
  Xconomy — Authority: 710
  Biotech , deals , people Luke Timmerman wrote: Alder Biopharmaceuticals keeps such a low profile that even after five years in business, few people in Seattle biotech know who they are. That changed yesterday as the private Bothell, WA-based company burst onto the local, and national, biotech scene by ...
  3 days ago

• Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion

  
  Xconomy — Authority: 710
  Biotech , deals , Rheumatoid Arthritis Luke Timmerman wrote: Alder Biopharmaceuticals has just struck one of the biggest biotech partnerships of the year, both in the Seattle area and nationally. The Bothell, WA-based developer of faster and cheaper technology for making antibody drugs has formed a ...
  4 days ago

• Looking Back: 2009 Tour of California a Perfect Barometer for Later Season Success

  
  Euro Peloton - Pro Cycling News — Authority: 123
  The 2009 Amgen Tour of California proved to be a good barometer for who would shine in 2009. Held in February at the beginning of the season, the nine day race was long enough and tough enough to show who would have the chops later in the season. Now scheduled for May, next years race will be a great indicator for who ...
  5 days ago

• Aranesp Associated With Increased Risk For Stroke In Patients With Diabetes And Chronic Kidney Disease

  
  Drug Injury Watch — Authority: 112
  TREAT Study Revealed, Also, That This Amgen Anemia Drug Was No Better Than Placebo In Reducing Deaths Or Cardiovascular Problems (Posted by Tom Lamb at DrugInjuryWatch.com ) The anemia drug Aranesp (darbepoetin alfa) might cause an increased risk for stroke in patients with diabetes and ...
  1 week ago

• Impactiviti Daily 110209

  
  Impactiviti blog — Authority: 540
  TODAY’S NEWS Takeda buys into Amylin ’s weight-loss drug portfolio – Takeda will pay $75 million upfront for medicines including Amylin’s pramlintide/metreleptin and davalintide, in the second phase of testing needed for U.S. regulatory approval, Osaka- based Takeda and San Diego-based Amylin said in ...
  1 week ago

• Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss Drugs

  
  Xconomy — Authority: 710
  Biotech , deals , obesity Luke Timmerman wrote: San Diego-based Amylin Pharmaceuticals, the dark horse in the race to develop a new breed of weight-loss drugs, has struck a partnership with Japan-based Takeda Pharmaceuticals that could be worth more than $1 billion over time if the drug reaches ...
  1 week ago

• 15 States Including California Are Suing Amgen – Alleging Kickbacks and Overfill Billings to Boost Sales of Aranesp

  
  The Medical Quack — Authority: 515
  The drug, Aranesp is used with chemotherapy and chronic renal failure to increase red blood cells and was approved by the FDA in 2001. We are hearing more about drug marketing today and now it’s spilling over to the “biotech” drug companies for investigation. The suit states that providers were bribed and ...
  2 weeks ago

• Amgen Is Accused of Illegal Kickbacks

  
  NYT > Theater — Authority: 911
  Amgen has been accused by 14 states of engaging in illegal kickbacks to promote sales of its anemia drug Aranesp.
  2 weeks ago

• Amgen Sued By 15 States Over Aranesp Kickbacks

  
  Pharmalot — Authority: 596
  The lawsuit charges Amgen - along with a specialty group purchasing organization known as International Nephrology Network and the ASD Healthcare wholesaler - with offering kickbacks to medical providers to increase sales of its Aranesp anemia drug, Aranesp. The multi-state suit, by the way, joins a whistleblower ...
  2 weeks ago

• 14 States and DC Sue Amgen, Amerisource Over Alleged Kickbacks

  
  HULIQ - Citizen News Review — Authority: 700
  The attorneys general of 14 states and the District of Columbia have filed a lawsuit against drugmaker Amgen Inc. and a major pharmaceutical distributor charging the companies colluded to defraud the Medicaid program and offer illegal kickbacks to physicians in order to boost sales of Amgens anemia drug Aranesp.
  2 weeks ago

• Amgen Sued By New York, 14 Other States

  
  socalTECH.com - Southern California High Tech News — Authority: 561
  Thousand Oaks-based biotech giant Amgen is the subject of a lawsuit being filed by New York Attorney General Andrew M. Cuomo, along with 14 other states, claiming that the biotech firm created a kickback scheme to boost drug sales. According to Cuomo, the lawsuit, filed today in federal court, claims that Amgen, ...
  2 weeks ago

• All of your cycling news – October 29, 2009

  
  Bike World News — Authority: 142
  In todays cycling news, confusion reigns around Contador, Bellis to return to Britain, Team Sky adds strength, Cadel Evans determined to win Tour de France and more... For the full story, go to http://www.bikeworldnews.com
  2 weeks ago

• UK Trust Sues Amgen & Wyeth Over Enbrel Patent

  
  Pharmalot — Authority: 596
  The Mathilda and Terence Kennedy Institute of Rheumatology Trust filed its lawsuit in federal court in Delaware, seeking royalties and damages from Wyeth and Amgen for infringing a patent for treating arthritis. The drug makers jointly market Enbrel, a best-selling med, for treating rheumatoid arthritis. In its ...
  2 weeks ago

• Santaris Nabs Isis, Amgen Vets

  
  Xconomy — Authority: 710
  Biotech , people , MicroRNA Luke Timmerman wrote: Santaris Pharma , the Danish company that has pushed the first microRNA therapy into clinical trials, has recruited a pair of big name executives from Isis Pharmaceuticals and Amgen Ventures to help lead its new U.S. subsidiary in San Diego. Mark Wedel, ...
  2 weeks ago

• Team Type 1 reveals 2010 Pro Men’s Roster

  
  Bike World News — Authority: 142
  Team Type 1 will field a versatile roster sprinkled with international flavor and experience when it begins its third season as a men’s professional team in 2010. For the full story, go to http://www.bikeworldnews.com
  2 weeks ago

• Armstrong to Miss Giro

  
  Come Cycling With Me — Authority: 134
  LOS ANGELES (USA): Lance Armstrong is set to miss next year’s Giro d’Italia after announcing he will race in the Tour of California. The California race starts on May 16 while the Giro, the world’s second-biggest stage race, begins on May 8. The seven-time Tour de France winner finished 12th in this year’s ...
  2 weeks ago

Comments about Amgen